RBC Bioscience Stock

RBC Bioscience Net Margin

The Net Profit Margin of RBC Bioscience (6848.TWO) as of Jul 24, 2026 is 10.51 %. In the previous year, Net Profit Margin was 3.73 % — a change of 181.83% (higher).

Net Margin

10.51 %

YoY

181.83%

Last updated:

Net Profit Margin of RBC Bioscience is 2026 10.51 % . Net Profit Margin of RBC Bioscience was 2025 3.73 % . It decreases by 181.83% higher compared to the previous year.

RBC Bioscience's net margin stands at 10.5%, down from 24.7% several years earlier.

Access this data via the Eulerpool API

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Net Profit Margin of RBC Bioscience is 10.51 % in 2026.

Access this data via the Eulerpool API

Margins — RBC Bioscience

All Key Metrics — RBC Bioscience